RADIX PHARMACEUTICALS, INC.

Company Information
Address 13303 Sunny Brooke Place
Room 101
Potomac, MD, -


Information

DUNS: 142006910

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of Small Molecules as Antiprotozoal Agents

    Amount: $1,240,336.00

    DESCRIPTION (provided by applicant): The proposed research focuses on the development of novel therapeutic agents for the prevention and treatment of malaria caused by P. falciparum. A previous Phase ...

    SBIRPhase II2012Department of Health and Human Services
  2. Preclinical Studies of Natural Product Derivatives as Antimalarial Agents

    Amount: $998,181.00

    DESCRIPTION (provided by applicant): This project focuses on the development of a novel therapeutic agent for preventing and treating P. falciparum malaria. A two-year Phase I research has discovered ...

    SBIRPhase II2011Department of Health and Human Services
  3. Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2008Department of Health and Human Services
  4. Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.

    Amount: $590,628.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2008Department of Health and Human Services
  5. Development of Natural Product as Antimalarial Agent

    Amount: $299,880.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase I2007Department of Health and Human Services
  6. Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents

    Amount: $604,800.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIRPhase II2006Department of Health and Human Services
  7. Synthesis and Evaluation of Novel Antimalarial Agents

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this research is to develop drugs that are safe and effective against drug-resistant malaria. Malaria is one of the most common infectious di ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government